Steven W. Brostoff

Medicine · Health Sciences

41h-index6.1kcitations103works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(19), T-cell and B-cell Immunology(14), Glycosylation and Glycoproteins Research(13), Immune Cell Function and Interaction(13), Chemical Synthesis and Analysis(12)

Publications103 total

Allergic Encephalomyelitis in Monkeys In by a Peptide from the Al Protein (clinical signs/peptide fragments/histopathology/enceph
2016
Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I study.
PubMed·1999· 69 cited
Tumor Cell Surface Expression of Granulocyte-Macrophage Colony-Stimulating Factor Elicits Antitumor Immunity and Protects from Tumor Challenge in the P815 Mouse Mastocytoma Tumor Model
The Journal of Immunology·1999· 46 citedOpen Access
Selection ofhprtMutant T Cells as Surrogates for Dividing Cells Reveals a Restricted T Cell Receptor BV Repertoire in Insulin-Dependent Diabetes Mellitus
Clinical Immunology·1999· 16 cited
Stabilization of poly-l-lysine/DNA polyplexes for in vivo gene delivery to the liver
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression·1999· 273 cited
POLY-L-LYSINE-<i>GRAFT</i>-PEG COMB-TYPE POLYCATION COPOLYMERS FOR GENE DELIVERY
Journal of Macromolecular Science Part A·1999· 16 cited
Results of a Phase II Rheumatoid Arthritis Clinical Trial Using T-Cell Receptor Peptides
1999· 10 cited
T cell receptor peptide vaccination in rheumatoid arthritis: A placebo-controlled trial using a combination of V3, V14, and V17 Peptides
Arthritis & Rheumatism·1998· 1 cited
T cell receptor peptide vaccination in rheumatoid arthritis: A placebo-controlled trial using a combination of V?3, V?14, and V?17 Peptides
Arthritis & Rheumatism·1998· 73 cited
HIV-1-specific functional immune measurements as markers of disease progression
Journal of Biomedical Science·1997· 7 cited
Results of a phase I clinical trial of a T-cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T-cell receptor utilization in CSF cell populations
Journal of Neuroimmunology·1997· 42 cited
Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRVβ6 CDR2 peptide
Journal of Neuroimmunology·1997· 57 cited
HIV-1-Specific Functional ImmuneMeasurements as Markers ofDisease Progression
Journal of Biomedical Science·1997· 1 cited
V beta 17 T cell receptor peptide vaccination in rheumatoid arthritis: results of phase I dose escalation study.
PubMed·1996· 42 cited
CD8<sup>+</sup> T‐Cells in Psoriatic Lesions Preferentially Use T‐Cell Receptors Vβ3 and/or Vβ13.1 Genes
Annals of the New York Academy of Sciences·1995· 56 cited
Vβ17 T‐Cell Receptor Peptide Vaccine
Annals of the New York Academy of Sciences·1995· 13 cited
Insulin-Secretory-Granule Specific T Cell Clones in Human IDDM
Journal of Autoimmunity·1995· 11 cited
T Cell Receptor Peptide Vaccines as Immunotherapy
Birkhäuser Basel eBooks·1995· 3 cited
The Development and Use of T Cell Receptor Peptide Vaccines
Advances in experimental medicine and biology·1995· 2 cited
Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis.
Journal of Clinical Investigation·1994· 45 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Dennis J. Carlo(13), E.H. Eylar(12), Seymour Greenfield(6), James M. Powers(5), Mark D. Howell(4), Daniel P. Gold(4), Tsaiwei Olee(3), Henry C. Powell(3), Richard M. Bartholomew(3), Henryk M. Wı́sniewski(3), Yashwant D. Karkhanis(3), Elizabeth E. Morgan(3), Steven P. Richieri(3), Larry Smith(3), Steven T. Winters(2), Paul R. Burnett(2), Jocelyn P. Diveley(2), Katherine A. Lundeen(2), Roland Martinꝉ(2), Henry F. McFarland(2)